ASNC-ACC-Letter-to-Congress_Price-Transparency-Legislation_02-01-2024
In February 2024, ASNC and the American College of Cardiology shared with Senate leaders concerns about the implications of Section 4 of S.3458, the Health Care PRICE Transparency Act 2.0, which posed an unnecessary administrative burden on already strained physician practices and would not have resulted in a patient-centric solution to price transparency. Section 4 would likely have impacted the vast majority of physicians, ranging from small family practices to specialists—all of whom provide imaging services in the office setting.
Resource Type
Health Policy Memos
Related Resources
PET Case: Very High-Risk PET MPI
Case summary: This case illustrates the value of cardiac PET MPI for…
PET Case: Role of PET/CT Myocardial Perfusion Imaging in Diagnosing INOCA
Case summary: This case illustrates the role of PET myocardial perfusion imaging…
Cardiac PET – Solutions for Adoption
Watch “Cardiac PET – Solutions for Adoption,” where you’ll delve into the…